Dry antibiotic pipeline: Regulatory bottlenecks and regulatory reforms.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance.Vaccine: X · 2023
   Review
2. Effects of antibiotic interaction on antimicrobial resistance development in wastewater.Scientific reports · 2023
   Article
3. The VirtuousAntibiotics (Basel, Switzerland) · 2023
   Review
4. Effects of Antibiotic Interaction on Antimicrobial Resistance Development in Wastewater.bioRxiv : the preprint server for biology · 2023
   Article
5. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?Chemical Society reviews · 2022
   Review
6. Existing evidence on antibiotic resistance exposure and transmission to humans from the environment: a systematic map.Environmental evidence · 2022
   Article
7. Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics.Iranian journal of basic medical sciences · 2021
   Review
8. BING, a novel antimicrobial peptide isolated from Japanese medaka plasma, targets bacterial envelope stress response by suppressing cpxR expression.Scientific reports · 2021
   Article
9. Strategies to Tackle Antimicrobial Resistance: The Example ofInternational journal of molecular sciences · 2021
   Review
10. Rekindling of a Masterful Precedent; Bacteriophage: Reappraisal and Future Pursuits.Frontiers in cellular and infection microbiology · 2021
    Review
11. Prescribing Patterns for Upper Respiratory Tract Infections: A Prescription-Review of Primary Care Practice in Quetta, Pakistan and the Implications.Frontiers in public health · 2021
    Article
12. Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections.Frontiers in cellular and infection microbiology · 2021
    Review
13. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.International journal of molecular sciences · 2020
    Review
14. Bioactive natural compounds against human coronaviruses: a review and perspective.Acta pharmaceutica Sinica. B · 2020
    Review
15. Vaccines Against Antimicrobial Resistance.Frontiers in immunology · 2020
    Review
16. Silica Nanoparticles-A Versatile Tool for the Treatment of Bacterial Infections.Frontiers in chemistry · 2020
    Review
17. What is the research evidence for antibiotic resistance exposure and transmission to humans from the environment? A systematic map protocol.Environmental evidence · 2020
    Article
18. Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Review
19. Restoring logic and data to phage-cures for infectious disease.AIMS microbiology · 2017
    Review
20. Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria.Applied and environmental microbiology · 2016
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.